Recent changes in population patterns of tobacco use in youth and adults underscore the potential substitution of other menthol tobacco products for cigarettes in the face of a ban on menthol in cigarettes. The increased use of cigars and pipe tobacco in youth following the 2009 ban on flavored cigarettes is particularly important given that flavored filtered little cigars are often indistinguishable from cigarettes and flavored pipe tobacco can be used to make roll-your-own cigarettes. Mentholated pipe tobacco (for roll-your-own cigarettes, mRYO), menthol filtered little cigars (mFLC), and non-menthol cigarettes (nmC) appear to be plausible substitutes for menthol cigarettes. The goal of the current study is to examine the abuse liability and substitutability of these potential menthol cigarette substitutes using an in-laboratory and ad libitum outpatient mixed design. Eighty current menthol cigarette smokers (n=40 aged 18-24 years, n=40 aged 25+ years) will complete a three-phase study: in Phase 1, utilizing a randomized crossover design, participants' will complete 4 smoking sessions, smoking a different product each session to examine each product's abuse liability, demand, and topography. Products will include participants' usual brand menthol cigarette (UBMC) as well as 3 commercially-available alternatives, including mFLC, an mRYO product, and preferred non-mentholated cigarette (nmC). In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and instructed to completely substitute the product for their UBMC for one week. Participants will complete ecological momentary assessments (EMA) during this period to more accurately assess substitution and perceived effects in real-time. In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task. In all phases, multiple domains of abuse liability will be assessed, including product administration (in-lab topography and EMA self-report measures), product liking/craving and withdrawal suppression (in-lab and EMA self-report). This study will be the first to estimate the substitutability of potential menthol cigarettes substitutes in adult smokers, which could impact the health benefit of a public health standard banning menthol in cigarettes. It will evaluate characteristics and perceptions (e.g., satisfaction, taste) of these products that may increase the likelihood of substitutability. Findings from this study will provide key information on the potential unintended consequences of a ban on menthol in cigarettes (i.e., the extent to which these substitutes would appeal to and be used by existing menthol cigarette smokers). They may also inform how FDA treats other non-cigarette tobacco products used as menthol cigarette substitutes in future proposed rulemaking, for example, extending the ban to menthol filtered little cigars or menthol pipe tobacco.

Public Health Relevance

FDA has repeatedly indicated its intent to pursue a ban on menthol in cigarettes. However, estimating the impact of a potential ban on menthol in cigarettes requires accounting for likely substitutes in the marketplace that may also need to be restricted to effectively protect public health. The proposed study uses an in- laboratory and ad libitum outpatient mixed design to examine the abuse liability and substitutability of plausible menthol cigarette alternatives, including menthol filtered cigars, menthol roll-your-own cigarettes, and non- menthol cigarettes, in a sample of current adult menthol cigarette smokers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DA046333-01A1
Application #
9647801
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Kautz, Mary A
Project Start
2018-09-15
Project End
2020-08-31
Budget Start
2018-09-15
Budget End
2019-08-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104